| CAS | 中文名稱 | 英文名稱 | MF |
|
2151823-08-2
|
甲基-二十四聚乙二醇-氨基
|
Methyl-PEG24-Amine
|
C49H101NO24
|
|
1094073-72-9
|
4,4-Difluoroazepane
|
4,4-Difluoroazepane
|
C6H11F2N
|
|
134415-42-2
|
對(duì)溴氯苯-D4
|
4-BROMOCHLOROBENZENE-D4
|
C6H4BrCl
|
|
6100-18-1
|
丁二酸鉀
|
POTASSIUNS SUCCINATE
|
C4H10K2O7
|
|
25114-81-2
|
六氫-1H-氮雜卓-1-甲醛
|
Hexahydro-1H-azepine-1-carbaldehyde
|
C7H13NO
|
|
206055-71-2
|
1-[5'-O-(4,4'-Dimethoxytrityl)-2-O,4-C-methylene-beta-D-ribofuranosyl]-5-methyluracil
|
1-[5'-O-(4,4'-Dimethoxytrityl)-2-O,4-C-methylene-beta-D-ribofuranosyl]-5-methyluracil
|
C32 H32 N2 O8
|
|
1257647-76-9
|
三丁基氯化錫-D27
|
TRIBUTYLTIN CHLORIDE-D27
|
C12ClD27Sn
|
|
1015854-55-3
|
鄰苯二甲酸二己酯-3,4,5,6-D4
|
DI-N-HEXYL PHTHALATE-3,4,5,6-D4
|
C20H30O4
|
|
192189-16-5
|
3-溴-1H-吡咯并[3,2-C]吡啶-1-甲酸叔丁酯
|
1-Boc-3-bromo-5-azaindole
|
C12H13BrN2O2
|
|
262366-32-5
|
尼達(dá)尼布雜質(zhì)E
|
Nintedanib impurity E
|
C29H31N5O2
|
|
881189-58-8
|
5-溴-2-氟苯丙酸
|
3-(5-Bromo-2-fluorophenyl)propionic acid
|
C9H8BrFO2
|
|
13797-63-2
|
2-三氟甲基-1H-咪唑并[4,5-B]吡啶
|
2-TRIFLUOROMETHYL-3H-IMIDAZO[4,5-B]PYRIDINE
|
C7H4F3N3
|
|
210530-70-4
|
(3,5-Difluoro-phenyl)-acetic acid methyl ester
|
(3,5-Difluoro-phenyl)-acetic acid methyl ester
|
C9H8F2O2
|
|
876403-98-4
|
Topiramate Impurity 6
|
Topiramate Impurity 6
|
C17H30N2O9S
|
|
1933514-13-6
|
KVD900
|
1H-Pyrazole-4-carboxamide, N-[(3-fluoro-4-methoxy-2-pyridinyl)methyl]-3-(methoxymethyl)-1-[[4-[(2-oxo-1(2H)-pyridinyl)methyl]phenyl]methyl]-
|
C26H26FN5O4
|
|
6918-15-6
|
二吡啶-4-基甲酮
|
dipyridin-4-ylmethanone(SALTDATA: FREE)
|
C11H8N2O
|
|
519164-14-8
|
Cyclopropyl-oxo-acetic acid ethyl ester
|
Cyclopropyl-oxo-acetic acid ethyl ester
|
C7H10O3
|
|
63779-86-2
|
氫氯噻嗪雜質(zhì)23
|
2H-1,2,4-Benzothiadiazine-7-sulfonamide,6-chloro-3,4-dihydro-4-nitroso-, 1,1-dioxide
|
C7H7ClN4O5S2
|
|
2072108-68-8
|
N 1 - (2-甲基-1-萘基)-N 2 - (苯基甲基) -乙二酰胺
|
Ethanediamide, N1-(2-methyl-1-naphthalenyl)-N2-(phenylmethyl)-
|
C20H18N2O2
|
|
1404053-60-6
|
棕櫚酸帕利哌酮N氧化物
|
4-(6-fluorobenzo[d]isoxazol-3-yl)-1-(2-(2-methyl-4-oxo-9-(palmitoyloxy)-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-3-yl)ethyl)piperidine 1-oxide
|
C39H57FN4O5
|
|
65807-22-9
|
L-脯氨酸-D3
|
L-PROLINE-2,5,5-D3
|
C5H9NO2
|
|
855398-58-2
|
6-氧雜螺[4.5]癸烷-9-醇
|
6-Oxaspiro[4.5]decan-9-ol
|
C9H16O2
|
|
849221-94-9
|
1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-phenyl-
|
1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-phenyl-
|
C28H25N3O5
|
|
49552-13-8
|
(1-乙基-4,5-二氫-1H-咪唑-2-基)氰胺
|
1-ethyl-2-cyanoiminoimidazolidine
|
C6H10N4
|
|
1363380-95-3
|
2-氧雜螺[3.3]庚-6-基甲醇
|
2-Oxa-spiro[3.3]heptane-6-Methanol
|
C7H12O2
|
|
14604-28-5
|
三十二碳二酸
|
1,32-dotriacontanedioic acid
|
C32H62O4
|
|
63139-97-9
|
(2-甲基噻唑-5-基)甲胺
|
(2-METHYL-1,3-THIAZOL-5-YL)METHYLAMINE
|
C5H8N2S
|
|
847445-81-2
|
西他列汀中間體
|
1,2,4-Triazolo[4,3-a]pyrazine, 7-[3-amino-1-oxo-4-(2,4,5-trifluorophenyl)-2-butenyl]-5,6,7,8-tetrahydro- 3-(trifluoromethyl)-
|
C16H13F6N5O
|
|
110578-73-9
|
Metronidazole Impurity 13
|
Metronidazole Impurity 13
|
C6H9N3O3
|
|
123195-72-2
|
對(duì)叔丁氧基苯乙醇
|
4-TERT-BUTOXYPHENETHYL ALCOHOL
|
C12H18O2
|
|
1581683-57-9
|
tertbutyl 5oxo2azaspiro[3.4]octane2carboxylate
|
tertbutyl 5oxo2azaspiro[3.4]octane2carboxylate
|
C12H19NO3
|
|
916420-62-7
|
3,6-二氯-2-氟苯甲酸
|
3,6-DICHLORO-2-FLUOROBENZOIC ACID
|
C7H3Cl2FO2
|
|
17274-64-5
|
1-(4-氨基吲哚啉)乙酮
|
1-(4-Aminoindoline)ethanone ,98%
|
C10H12N2O
|
|
1346603-00-6
|
2-（叔丁基氨基）-3',5'-二氯苯乙酮鹽酸鹽
|
2-(tert-Butylamino)-3',5'-dichloropropiophenone Hydrochloride
|
C13H18Cl3NO
|
|
1643116-22-6
|
Tenofovir Impurity 117
|
Tenofovir Impurity 117
|
C8H11N5O
|
|
479611-96-6
|
4-甲磺酰基-哌啶
|
4-(Methylsulfonyl)-piperidine HCl
|
C6H14ClNO2S
|
|
1256345-61-5
|
5-氰基-2-(甲氧基甲氧基)苯硼酸
|
5-Cyano-2-(MOMO)phenylboronic acid
|
C9H10BNO4
|
|
1174289-22-5
|
BAZEDOXIFENE-N-OXIDE
|
1-[[4-[2-(Hexahydro-1-oxido-1H-azepin-1-yl)ethoxy]phenyl]Methyl]-2-(4-hydroxyphenyl)-3-Methyl-1H-indol-5-ol
|
C30H34N2O4
|
|
73312-69-3
|
依托度昔布雜質(zhì)Ⅴ
|
Etoricoxib Impurity 15
|
C5H8ClNO
|
|
845908-98-7
|
(R)-3-氨基-3-(4-溴苯基)丙酸甲酯鹽酸鹽
|
(R)-Methyl 3-amino-3-(4-bromophenyl)propanoate HCl
|
C10H13BrClNO2
|
|
25768-50-7
|
聚(環(huán)己基丙烯酸酯)
|
POLY(CYCLOHEXYL METHACRYLATE)
|
C10H16O2
|
|
1101167-84-3
|
4-烯普瑞巴林
|
(R)-4,5-Dehydro Pregabalin
|
C8H15NO2
|
|
952-10-3
|
2,3-二氧代-1,2,3,4-四氫喹喔啉-6-磺酰氯
|
2,3-DIOXO-1,2,3,4-TETRAHYDROQUINOXALINE-6-SULFONYL CHLORIDE
|
C8H5ClN2O4S
|
|
161647-06-9
|
5-甲基吡啶-2-甲胺鹽酸鹽
|
(5-METHYLPYRIDIN-2-YL)METHYLAMINE
|
C7H11ClN2
|
|
1803449-02-6
|
2,2'-(disulfanediylbis(methylene))bis(1-(5-methoxy-1H-benzo[d]imidazol-2-yl)-3,5-dimethylpyridin-4(1H)-one)
|
2,2'-(disulfanediylbis(methylene))bis(1-(5-methoxy-1H-benzo[d]imidazol-2-yl)-3,5-dimethylpyridin-4(1H)-one)
|
C32H32N6O4S2
|
|
2295862-29-0
|
立他司特雜質(zhì)3
|
Lifitegrast Impurity 3
|
C30H26Cl2N2O7S
|
|
597554-76-2
|
5,5,10,10,15,15-六甲基-二茚并[1,2-A:1',2'-C]芴
|
10,15-Dihydro-5,5,10,10,15,15-hexamethyl-5H-tribenzo[a,f,k]trindene
|
C33H30
|
|
21767-15-7
|
3-苯氧吡咯烷鹽酸鹽
|
3-PHENOXYPYRROLIDINE HYDROCHLORIDE
|
C10H14ClNO
|
|
933191-25-4
|
2,2'-聯(lián)嘧啶-5-羧酸
|
2-(Pyrimidin-2-yl)pyrimidine-5-carboxylic acid
|
C9H6N4O2
|
|
1097652-83-9
|
4,6-雙(3,5-二(4-吡啶)基苯基)-2-苯基嘧啶
|
4,6-Bis(3,5-di(pyridin-4-yl)phenyl)-2-phenylpyrimidine
|
C42H28N6
|
|
52934-83-5
|
七尾霉素
|
NANAOMYCIN A
|
C16H14O6
|
|
6314-70-1
|
4-(CYCLOHEXYLSULFAMOYL)BENZOIC ACID
|
4-(cyclohexylsulfamoyl)benzoic acid
|
C13H17NO4S
|
|
61423-61-8
|
1,2-十六烷基磷脂酰乙醇胺
|
L-BETA,GAMMA-DIHEXADECYL-ALPHA-CEPHALIN
|
C37H78NO6P
|
|
1086062-90-9
|
6-溴-4-氯-8-甲基喹啉
|
6-Bromo-4-chloro-8-methylquinoline
|
C10H7BrClN
|
|
1211588-35-0
|
6-ETHYNYLPYRIDINE-3-CARBONITRILE 250MG
|
2-Ethynylpyridine-5-carbonitrile
|
C8H4N2
|
|
1332389-57-7
|
阿帕他胺去氟雜質(zhì)
|
Apalutamide Desfluoro Impurity
|
C21H16F3N5O2S
|
|
1383814-68-3
|
阿維巴坦雜質(zhì)3
|
Avibactam Impurity 3(2R,5S)
|
C7H12N3NaO6S
|
|
258530-57-3
|
3-羥基嘧啶-1-乙酸
|
1-Pyrrolidineacetic acid, 3-hydroxy- (9CI)
|
C6H11NO3
|
|
25162-00-9
|
R-（+）-尼古丁
|
(+)-NICOTINE-(+)-DI-P-TOLUOYL TARTRATE
|
C10H14N2
|
|
260267-07-0
|
5,6-二氟-1H-吲哚-3-甲醛
|
5,6-Difluoro-1H-indole-3-carboxaldehyde
|
C9H5F2NO
|
|
907565-13-3
|
N,S-(二羧甲基)半胱氨酸
|
N,S-Carboxymethyl Cysteine
|
C7H11NO6S
|
|
197706-51-7
|
奈比洛爾雜質(zhì)
|
(+)-(S,R)-6-fluoro-3,4-dihydro-2-(2-oxiranyl)-2H-1-benzopyran
|
C11H11FO2
|
|
110954-19-3
|
2-Piperazineaceticacid,5-methyl-3,6-dioxo-,(2S,5S)-(9CI)
|
2-Piperazineaceticacid,5-methyl-3,6-dioxo-,(2S,5S)-(9CI)
|
C7H10N2O4
|
|
5728-65-4
|
2-(4-氨基苯基)聯(lián)苯
|
[1,1':2',1''-Terphenyl]-4-amine (9CI)
|
C18H15N
|
|
138907-80-9
|
1-(4-氯苯基)吡唑-4-甲酸
|
1-(4-chlorophenyl)-1H-pyrazole-4-carboxylic acid
|
C10H7ClN2O2
|
|
189016-90-8
|
納曲酮EP雜質(zhì)C
|
Naltrexone EP Impurity C
|
C20H23NO4
|
|
75704-24-4
|
WAY 161503鹽酸鹽
|
8,9-DICHLORO-2,3,4,4A-TETRAHYDRO-1H-PYRAZINO[1,2-A]QUINOXALIN-5(6H)-ONE HYDROCHLORIDE
|
C11H11Cl2N3O
|
|
71140-58-4
|
多粘菌素B3
|
Octanoylpolymyxin B
|
C55H96N16O13
|
|
38452-49-2
|
3,4-二甲基苯甲硫砜
|
3,4-DIMETHYLPHENYLMETHYLSULFONE
|
C9H12O2S
|
|
3929-47-3
|
3-(3,4-二甲氧苯基)-1-丙醇
|
3-(3,4-DIMETHOXYPHENYL)-1-PROPANOL
|
C11H16O3
|
|
13057-98-2
|
芐青霉素酸
|
benzylpenicilloic acid
|
C16H20N2O5S
|
|
2641451-73-0
|
(S)-2-(BOC-氨基)-3-(4-溴-2-噻唑基)丙酸甲酯
|
2-Thiazolepropanoic acid, 4-bromo-α-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl ester, (αS)-
|
C12H17BrN2O4S
|
|
126-90-9
|
(S)-3,7-二甲基-1,6-辛二烯-3-醇
|
(S)-3,7-dimethyl-1,6-octadien-3-ol
|
C10H18O
|
|
897045-90-8
|
Vitamin B5 Impurity 1
|
Vitamin B5 Impurity 1
|
C12H22N2O6
|
|
71074-44-7
|
甲氨蝶呤雜質(zhì)
|
methotrexate-gamma-dimethylamide
|
C22H27N9O4
|
|
875245-69-5
|
5-溴-4-甲氧基-2-甲基苯甲酸
|
5-BROMO-4-METHOXY-2-METHYLBENZOIC ACID
|
C9H9BrO3
|
|
1928729-31-0
|
Edoxaban Impurity 20 (1R,2R,4S)
|
Edoxaban Impurity 20 (1R,2R,4S)
|
C16H29N3O7
|
|
616234-56-1
|
Erythromycin EP Impurity M
|
Erythromycin EP Impurity M
|
C37H67NO13
|
|
1630906-37-4
|
cis-2H-Pyran-4-amine, 3-fluorotetrahydro- hydrochloride
|
cis-2H-Pyran-4-amine, 3-fluorotetrahydro- hydrochloride
|
C5H11ClFNO
|
|
1305323-24-3
|
3-碘-1-(氧雜-2-基)吡唑
|
3-Iodo-1-(oxan-2-yl)pyrazole
|
C8H11IN2O
|
|
32998-03-1
|
2,6-二氯-N-甲基嘧啶-4-胺
|
2,6-DICHLORO-N-METHYL-4-PYRIMIDINAMINE
|
C5H5Cl2N3
|
|
38990-16-8
|
methyl (41R,12R,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
|
methyl (41R,12R,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
|
C21H26N2O3
|
|
861069-45-6
|
4-異丙氧基-3-甲氧基苯乙腈
|
2-(4-Isopropoxy-3-Methoxyphenyl)acetonitrile
|
C12H15NO2
|
|
412293-42-6
|
8-甲基-1,4-二氧雜螺[4.5]癸烷-8-羧酸
|
8-Methyl-1,4-dioxaspiro[4.5]decane-8-carboxylic acid
|
C10H16O4
|
|
22348-96-5
|
3-氧代癸酸甲酯
|
methyl 3-oxodecanoate
|
C11H20O3
|
|
4373-61-9
|
2-(3-甲苯基)吡啶
|
2-M-tolylpyridine
|
C12H11N
|
|
37945-07-6
|
(5-氯-2-(3-(氯甲基)-5-甲基-4H-1,2,4-三唑-4-基)苯基)(苯基)甲酮
|
Alprazolam EP Impurity F
|
C17H13Cl2N3O
|
|
2999-40-8
|
間苯三酚三乙酸酯
|
PHLOROGLUCINOL TRIACETATE
|
C12H12O6
|
|
2285346-44-1
|
Ilaprazole Impurity 5 (Ilaprazole Pyridine N-Oxide)
|
Ilaprazole Impurity 5 (Ilaprazole Pyridine N-Oxide)
|
C19H18N4O3S
|
|
165806-53-1
|
化合物 T28681
|
SB 220025
|
C18H19FN6
|
|
103460-87-3
|
8-氟-3-乙酯加替沙星
|
3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(3-Methyl-1-piperazinyl)-4-oxo-, ethyl ester
|
C20H23F2N3O3
|
|
1105664-04-7
|
7,9-二氧代-2,6-二氮雜螺[3.5]壬烷-2-羧酸叔丁酯
|
2-Boc-7,9-dioxo-2,6-diazaspiro[3.5]nonane
|
C12H18N2O4
|
|
957035-15-3
|
3-氯甲基苯基硼酸
|
3-boronobenzyl chloride
|
C7H8BClO2
|
|
70336-49-1
|
利多卡因雜質(zhì)2
|
Lidocaine Impurity
|
C20H22N2O2
|
|
3001-66-9
|
仲辛硫醇
|
2-Octanethiol
|
C8H18S
|
|
1682660-39-4
|
雷芬那新雜質(zhì)1
|
Carbamic acid, N-[1,1'-biphenyl]-2-yl-, 1-[2-[[4-(hydroxymethyl)benzoyl]methylamino]ethyl]-4-piperidinyl ester
|
C29H33N3O4
|
|
775233-43-7
|
頭孢替安雜質(zhì)1
|
Cefotiam Impurity 1
|
C13H14N4O5S2
|
|
357426-10-9
|
伐倫克林雜質(zhì)
|
Hydroxy Varenicline N-Trifluoroacetate
|
C15H12F3N3O2
|
|
3729-21-3
|
4-異氰基苯甲酰氯
|
4-ISOCYANATOBENZOYL CHLORIDE
|
C8H4ClNO2
|
|
1212182-03-0
|
(R)-N-BOC-3-(2-羥乙基)吡咯烷
|
(R)-tert-butyl 3-(2-hydroxyethyl)pyrrolidine-1-carboxylate
|
C11H21NO3
|